John L. Brottem, General Counsel at Outset Medical (NASDAQ: OM), sold 2,638 shares on May 15, 2026. The transaction totaled $9,760, with shares sold at $3.70 each.
The sale was a "sell to cover" transaction to satisfy tax withholding obligations from vested RSUs. Brottem directly holds 30,277 shares after the sale.
Bond.az analysis suggests the stock appears undervalued. Outset Medical's Q1 2026 revenue fell 6% to $27.9 million, but full-year guidance of $125-130 million was reaffirmed.












